Anti-osteoporosis therapy
Anti-osteoporosis therapy has been studied in 2 papers since 2023: 2 observational studies in people. The newest paper, Jun 1, 2023: “Effects of anti-osteoporosis therapy on the risk of secondary fractures and surgical complications following surgical fixation of proximal humerus fracture in older people”.
2 papers study it2 findingsUpdated
“significant reduction of secondary fracture risk by anti-osteoporotic therapy (P < 0.001)”
None of its findings points the other way.
- 1 lab
- Funder: Universität Münster
- Humans2
What is Anti-osteoporosis therapy linked with?
2Studies link Anti-osteoporosis therapy with 2 measures, most often surgical complications (1 study) and secondary fracture (1).
Surgical complications
downin humans1
1 study
Surgical complications
downin humans1
Anti-osteoporosis therapy lowers the risk of surgical complications in humans.
“increased risk for surgical complications (hazard ratio: 1.35, 95% confidence interval: 1.25-1.47, P < 0.001) after LPF could be reversed by anti-osteoporotic therapy”
Humansafter locked plate fixationn = 43,310
Age and ageing
Secondary fracture
downin humans1
1 study
Secondary fracture
downin humans1
Anti-osteoporosis therapy lowers the risk of secondary fracture in humans (P < 0.001).
“significant reduction of secondary fracture risk by anti-osteoporotic therapy (P < 0.001)”
Humansn = 43,310
Age and ageing